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ABSTRACT
The period of both in vitro maturation (IVM) and incubation with oocyte activators affects the blastocyst yield 
following parthenogenetic activation (PA). Nevertheless, it is still unknown how these conditions impact the expansion 
and hatching rates of bovine parthenogenetic blastocysts. The objective of this study was to assess the influence 
of the duration of IVM and exposure to the activating agent, 6-dimethylaminopurine (6-DMAP), on a number of 
developmental parameters in bovine parthenotes, including: Cleavage, blastocyst formation, expansion, and hatching. 
Slaughterhouse oocytes were subjected to different periods of IVM. Subsequently, eggs were first parthenogenetically 
activated for five minutes with ionomycin and then incubated for distinct lengths of time with a second activator, 
6-DMAP. The treatments were: a) Control: 22 h IVM/4 h 6-DMAP; b) 22 h IVM/5 h 6-DMAP; c) 24 h IVM/4 h 
6-DMAP; and d) 24 h IVM/5 h 6-DMAP. Developmental stages were evaluated at day 4 and day 8 of in vitro culture 
(IVC). No differences were detected in most developmental parameters. However, the duration of IVM and incubation 
with 6-DMAP significantly affected (P<0.05) hatching capacity considering the number of blastocysts (Hatch./Blast.). 
Also, this same variable was higher (P<0.05) in group b) 22 h IVM/5 h 6-DMAP (45.89 ± 12.59%), as compared to 
c) 24 h IVM/4 h 6-DMAP (6.67 ± 6.67%). In conclusion, the length of IVM and incubation with 6-DMAP influenced 
parthenogenetic development, where 22 h IVM/5 h 6-DMAP was the condition producing the highest Hatch./Blast. 
rate in bovine parthenotes.
Key words: in vitro maturation; 6-dimethylaminopurine; culture length; parthenogenesis; bovine_____________________________________________________________________________________________
DOI: 10.24099/vet.arhiv.0930
________________
*Corresponding author:
Andrés Quezada-Casasola, DVM, PhD, Departament of Veterinary Sciences, Biomedical Sciences Institute, Autonomous University of 
Ciudad Juarez, Anillo Envolvente Pronaf y Estocolmo s/n, Ciudad Juarez 32310, Mexico; +52 656 688 1800 X 1667; Fax: +52 656 688-1825; 
E-mail: aquezada@uacj.mx
#Both authors contributed equally
E. Orozco-Lucero et al.: Incubation times and bovine in vitro parthenogenesis
Vet. arhiv 90 (5), 527-534, 2020528
Introduction
In vitro embryo production (IVP) is widely 
employed as a physiological study model. 
Results obtained from embryos generated by in 
vitro fertilization (IVF) are complemented with 
research of embryos generated by parthenogenetic 
activation (PA) (MUÑOZ et al., 2015). Parthenotes 
are embryos produced after induction of egg cell 
division in the absence of a spermatozoon. Due to 
the absence of a paternal genome, experimentally-
produced parthenotes usually do not yield viable 
offspring upon transfer to foster mothers (BREVINI 
et al., 2012). Moreover, the in vitro parthenogenetic 
developmental rates are generally lower than those 
of IVF-embryos during the first eight days of in 
vitro culture (IVC) (NAKAMURA and KIKUCHI, 
2017). Therefore, strategies to improve results 
obtained from PA systems are still required.
As indicated by ANCCO et al. (2015), similar 
to IVP, experimental parthenogenesis relies on both 
IVM and IVC. PA can be carried out by egg membrane 
depolarization using chemical stimulation (e.g., 
strontium, ethanol, calcium ionophores), blockage 
of the extrusion of the second polar body, or by 
a chemically-induced decrease in the activity of 
maturation promoting factor (MPF) (DE MACEDO 
et al., 2019). An example of the last strategy is the 
inhibition of kinases by 6-dimethylaminopurine 
(6-DMAP) (LEE et al., 2018). It has been reported 
that the duration of both IVM and egg activation, 
as well as the type of chemical activating agent 
(or the combination of several of them), influences 
the developmental outcome of bovine parthenotes. 
Such chemical induction might include a first step 
of activation with ionomycin, a calcium ionophore, 
followed by incubation with 6-DMAP as a second 
activator (MÉO et al., 2007). Nevertheless, it is not 
yet evident in which way the incubation time during 
IVM and PA affects the course of parthenogenesis, 
beyond initial blastocyst formation, namely 
expansion and hatching. This could probably be 
due to the gradual inhibition of MPF activity upon 
longer periods of both IVM and incubation with 
kinase inhibitors (BASTOS et al., 2008). In this 
regard, it has been recently reported that insecticide-
induced suppression of MPF activity interferes 
with parthenogenetic blastocyst expansion and 
hatching in pigs (NIE et al., 2019). Consequently, 
we hypothesized that the length of IVM and PA 
involving MPF activity suppression, influences 
bovine parthenote developmental parameters, 
including expansion and hatching. Thus, the 
objective of the present study was to explore how 
distinct periods of both IVM and MPF inhibition 
impact the course of bovine parthenogenesis, 
in terms of cleavage, expanded blastocyst, and 
hatching rates, to improve PA protocols in cattle.
Materials and methods
All chemicals were purchased from Sigma-
AldrichⓇ (St. Louis, MO), whereas the culture 
media were from IVF Bioscience (Falmouth, UK), 
unless otherwise stated.
Oocyte collection. One hundred and sixty-
five bovine ovaries were obtained from a local 
slaughterhouse according to the NOM-051-
ZOO-1995 and NOM-033-ZOO-1995 national 
animal welfare guidelines. Collected ovaries were 
transported to the laboratory in 0.9% (w/v) NaCl 
at 29-35 °C. Follicles of 2-8 mm in diameter 
were aspirated using a 20-gauge needle after 2-3 
h postmortem. The collected follicular fluid was 
heparinized (5 IU/mL; PisaⓇ, Guadalajara, México).
In vitro maturation. Cumulus-oocyte-complexes 
(COCs) were washed three times in BO-WASH 
medium at 37 °C. COCs of categories 1 to 3 
(full-size oocytes with homogeneous cytoplasm; 
multiple layers of cumulus showing no expansion, 
without or with just slight signs of peripheral 
atresia) were selected (BLONDIN and SIRARD, 
1995). Subsequently, the COCs were placed in 
previously equilibrated BO-IVM, at a density of 
45 COCs/500 μL. The COCs were matured in vitro 
at 38.5 °C/6.5% CO2/100% relative humidity (RH) 
either for 22- or 24 h, according to the treatment.
Parthenogenetic activation. For denudation 
purposes, mature COCs were placed in BO-WASH 
at 37 °C, and supplemented with 0.33 mg/mL 
hyaluronidase. Then, the oocytes were denuded 
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with a micropipette and washed twice in BO-WASH 
without hyaluronidase. Groups of 10-40 oocytes 
were immersed in 50 μL-droplets of equilibrated 
(in the incubator) BO-IVF medium, containing 5 
μM ionomycin, and covered with mineral oil. This 
initial activation step was performed at 38.5°C/6.5% 
CO2/100% RH for 5 min. The instant when the 
oocytes started incubation with the ionophore was 
considered as 0 h post-parthenogenetic activation 
(0 hPA). Following the first activation, presumptive 
zygotes (p-Zy) were washed three times in BO-
WASH. After that, the p-Zy were exposed to 
6-DMAP as a second activating agent (MÉO et al., 
2007; BASTOS et al., 2008). Around 10-40 p-Zy 
were introduced in droplets of 50 μL of BO-IVF 
supplemented with 2.8 mM 6-DMAP. Parthenotes 
were cultured in the presence of 6-DMAP as 
described above, either for 4 or 5 h, according to 
the treatment.
In vitro culture. After incubation with 6-DMAP, 
all p-Zy were washed three times with BO-
WASH. Ten p-Zy were allocated in droplets of 
10 μL of BO-IVC medium. The p-Zy were then 
cultured at 38.5°C/6% O2/6% CO2/88% N2, and 
parthenogenetic cleavage was assessed at 96 hPA. 
All parthenotes continued in IVC until 192 hPA. 
At this last time point, visual evaluation was 
performed for blastocyst formation, expansion, and 
hatching (hatching considered the sum of hatching 
and hatched blastocysts).
Experimental design. It was determined the effect 
of two distinct periods of IVM (22-, 24 h), as well 
as that of two different lengths (4-, 5 h) of 6-DMAP 
incubation, on parthenogenetic development. 
Consequently, the treatments were the following: a) 
Control, 22 h IVM/4 h 6-DMAP; b) 22 h IVM/5 h 
6-DMAP; c) 24 h IVM/4 h 6-DMAP; and d) 24 h 
IVM/5 h 6-DMAP. Five replicates were used for the 
Control treatment, and six for all the other groups. 
All replicates were employed for parthenogenetic 
developmental evaluation at both the cleavage and 
blastocyst stages. 
Statistical analysis. The statistical package 
GraphPad Prism 8.0.0 for Windows (GraphPad 
Software; San Diego, CA; www.graphpad.com) was 
used. All data were expressed as mean percentage ± 
SEM. The effect of the treatment (duration of IVM 
and incubation with 6-DMAP) was evaluated by 
one-way analysis of variance (ANOVA), followed 
by a Tukey test as a post hoc analysis, to compare 
the means of all the treatments. A value of P≤0.05 
was deemed significant.
Results 
In this study, it was possible to produce bovine 
parthenotes able to cleave (Fig. 1) and progress up 
to blastocyst formation, expansion, and hatching 
(Fig. 2). 
As shown in Fig. 3A-F, no significant 
differences were detected in most of the 
developmental parameters evaluated, including: 
Cleavage; parthenotes of 8 to 16 cells (8-16C); 
total blastocysts (Blast.); blastocysts able to expand 
considering the number of COCs placed into 
IVM (Exp./COCs IVM); hatching (or hatched) 
blastocysts considering the number of COCs into 
IVM (Hatch./COCs IVM); or blastocysts able to 
expand considering the number of total blastocysts 
(Exp./Blast.). Nevertheless, the treatment (duration 
of IVM and incubation with 6-DMAP) showed a 
significant effect (P<0.05; Fig. 3G) on the hatching 
rate considering the number of blastocysts (Hatch./
Blast.). 
In detail, as shown in Fig. 3G, group b) 22 h IVM/5 
h 6-DMAP showed a significantly higher (P<0.05) 
percentage of Hatch./Blast. (45.89 ± 12.59%) when 
compared against c) 24 h IVM/4 h 6-DMAP (6.67 ± 
6.67%).
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Fig. 2. Bovine parthenogenetic blastocysts generated after distinct periods of in vitro maturation (IVM) and incubation 
with 6-dimethylaminopurine. A, Control: 22 h of IVM and 4 h of incubation with 6-dimethylaminopurine (6-DMAP); 
B, 22 h IVM/5 h 6-DMAP; C, 24 h IVM/4 h 6-DMAP; D, 24 h IVM/5 h 6-DMAP. Arrowhead, early blastocyst; arrow, 
expanded blastocyst; asterisk, hatching blastocyst. Scale bar = 120 µm.
Fig. 1. Bovine parthenotes during the cleavage stage. Cumulus-oocyte complexes were matured in vitro during 22 
h. Upon activation, eggs were incubated during 4 h with 6-dimethylaminopurine. A, 2-cell parthenote; B, 4-cell 
(arrowhead); C, early 8-cell (early was considered when 5 to 8 cells; arrow); D, late 8-cell (late when 10 to 16 cells; 
asterisk). Scale bar = 120 µm
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Fig. 3. Parthenogenetic development after distinct periods of in vitro maturation (IVM) and incubation with 
6-dimethylaminopurine. A, cleavage percentage; B, the percentage of parthenotes with 8 to 16 cells (8-16C). 
C, total blastocyst percentage (Blast.); D, the percentage of blastocysts able to expand considering the number 
of cumulus-oocyte complexes placed into IVM (Exp./COCs IVM). E, the percentage of hatching (or hatched) 
blastocysts considering the number of COCs placed into IVM (Hatch./COCs IVM); F, the percentage of blastocysts 
able to expand considering the number of total blastocysts (Exp./Blast.); G, the percentage of hatching (or hatched) 
blastocysts considering the number of total blastocysts (Hatch./Blast.). One-way analysis of variance (ANOVA) 
detected a significant effect (P<0.05) of the treatment on Hatch./Blast. rate, whereas a Tukey test showed significant 
differences between experimental groups b and c (P<0.05). a, Control: 22 h IVM and 4 h of post-parthenogenetic 
activation incubation with 6-dimethylaminopurine (6-DMAP). n = 178 COCs, n = 45 Blast.; b, 22 h IVM/5 h 
6-DMAP. n = 226 COCs, n = 40 Blast.; c, 24 h IVM/4 h 6-DMAP. n = 212 COCs, n = 28 Blast.; d, 24 h IVM/5 h 
6-DMAP. n = 197 COCs, n = 32 Blast. The bars show the mean ± SEM. Significant differences were considered 
when P≤0.05 (*).
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discussion
In the current research, the selection of 
ionomycin followed by 6-DMAP as the activation 
procedure aimed at using an efficient method to 
produce bovine parthenotes. MÉO et al. (2007) 
reported that the conjunction of such ionophore 
and kinase inhibitor was the optimal condition 
for bovine PA. Here, we included a treatment 
consisting of 22 h IVM and 4 h 6-DMAP as a 
Control group since this was the initial condition 
(combination of incubation times) in the work by 
MÉO et al. (2007), also focused on the efficiency of 
cattle PA systems. Thus, the present study aimed to 
determine the influence of different combinations of 
the length of IVM and kinase activity suppression 
on cattle parthenote development. This goal was 
studied in the short and long term over eight days 
of IVC under the most suitable conditions in our 
laboratory. These included an IVM period no 
longer than 24 h. Moreover, several parameters, 
which reflect the capacity to progress to further 
development across species, and also specifically in 
cattle, were assessed. These parameters included: 
Cleavage (OROZCO-LUCERO et al., 2014; 
BOHRER et al., 2015), development to the 8-16 
cell stage (GONZÁLEZ-GRAJALES et al., 2015), 
total blastocyst formation, and the number of 
blastocysts able to expand and hatch (HOELKER 
et al., 2006; MORATÓ et al., 2016). To the best 
of our knowledge, this study is one of the few 
monitoring bovine parthenote 8-16 cell rate, 
blastocyst expansion, and hatching as a response to 
any treatment (PARK et al., 2017; DAIGNEAULT 
et al., 2018). Furthermore, this report is the first 
focusing on the impact of the activation method on 
the aforementioned developmental parameters, all 
at once, in cow parthenotes.
Findings from MÉO et al. (2007) suggested 
that longer IVM renders higher cow blastocyst 
formation. It has been proposed that the improved 
performance of PA models after extended IVM 
is due to attainment of cytoplasmic maturation. 
Furthermore, it is plausible that the progressive 
reduction of histone kinase activity when IVM is 
prolonged facilitates the transition from M-II to the 
first mitotic cycle (WANG et al., 2008; SHIRAZI 
et al., 2009). On the other hand, it has been 
discovered that after ionophore-based activation, 
the exposure to a kinase activity inhibitor (like 
6-DMAP, bohemine, or roscovitine) improves the 
outcome of parthenogenetic development (MÉO 
et al., 2007; PERECIN et al., 2007). Nevertheless, 
we did not detect any developmental advantage of 
parthenotes originated following 24 h of IVM. This 
may imply that this was because the extension of 
2 h of maturation did not cause enough additional 
cytoplasmic changes (or a gradual decrease in kinase 
activity) compared to 22 h of IVM. Therefore, 
future experiments with long IVM periods, such 
as those of 26 and 30 h assayed by MÉO et al. 
(2007), concomitantly with more prolonged 
incubation with 6-DMAP, could help to elucidate if 
a synergistic effect can be generated. On the other 
hand, it is plausible that the longer kinase inhibition 
(and the consequent decline in MPF activity) 
when the 6-DMAP incubation lasted 5 instead of 
4h, generated the observed surplus of hatching 
capacity (Hatch./Blast). Accordingly, BASTOS et 
al. (2008) described higher bovine parthenogenetic 
blastocyst formation upon 5 h of incubation with 
6-DMAP, than in protocols using just 4 h (MÉO 
et al., 2007). Thus, it can be inferred that those 
parthenotes originated after the longer kinase 
inhibition had increased developmental capacity. 
This competence seemingly manifested late here 
as amplified hatching potential. Understanding 
the underlying physiological fundaments of these 
changes deserves detailed exploration in the future.
Conclusions
The length of IVM and incubation with kinase 
inhibitor influenced the development of parthenotes. 
The treatment consisting of 22 h IVM/5 h 6-DMAP 
showed increased parthenogenetic blastocyst 
hatching. These conditions could be applied to 
enhance the performance of bovine PA systems.
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SAžETAK
Vrijeme in vitro sazrijevanja (IVM) i vrijeme inkubacije s aktivatorima oocista utječu na stvaranje blastocista nakon 
partenogenetske aktivacije (PA). Ipak, još uvijek se ne zna kako navedeno utječe na ekspanziju i stopu izlijeganja 
goveđih partenogenetskih blastocista. Cilj rada bio je istražiti utjecaj trajanja IVM i izloženosti aktivirajućem 
čimbeniku 6-dimethylaminopurinu (6-DMAP) na više razvojnih parametara u goveđih partenota, uključujući diobu, 
formiranje blastociste, ekspanziju i izlijeganje. Oocite prikupljene u klaonicama bile su podvrgnute različitom trajanju 
IVM. Nakon toga jajašca su prvo partenogenetski aktivirana s ionomicinom kroz 5 minuta i nakon toga inkubirana 
tijekom određenih vremenskih razdoblja sa drugim aktivatorom, 6-DMAP. Protokoli po istraženim skupinama bili 
su sljedeći: a) kontrolna skupina 22 h IVM/4 h 6-DMAP, b) skupina 22 h IVM/5 h 6-DMAP, c) skupina 24 h IVM/4 
h 6-DMAP i d) skupina 24 h IVM/5 h 6-DMAP. Razvojni stadiji in vitro kulture (IVC) procijenjivani su 4. i 8. dan. 
Za većinu razvojnih parametara nisu utvrđene razlike između istraženih skupina. Ipak, trajanja IVM i inkubacije sa 
6-DMAP znakovito su utjecali (P<0,05) na kapacitet izlijeganja kad se u obzir uzme broj blastocista (izlijeganja/
blasociste). Također, isti pokazatelji bili su viši (P<0,05) u skupini b) 22 h IVM/5 h 6-DMAP (45,89 ± 12,59 %) u 
odnosu na skupinu c) 24 h IVM/4 h 6-DMAP (6,67 ± 6,67 %). Zaključno, trajanje IVM i inkubacije sa 6-DMAP 
utjecali su na partenogenetski razvoj, pri čemu je 22 h IVM/5 h 6-DMAP kombinacija koja u goveđih partenota 
proizvodi najvišu stopu za pokazetelj izlijeganje/blasociste. 
Ključne riječi: sazrijevanje in vitro; 6-dimetilaminopurin; trajanje kulture; vrijeme inkubacije, partenogeneza; 
goveda_____________________________________________________________________________________________
